Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Takasago International Corporation ( (JP:4914) ) is now available.
Takasago International Corporation’s board has resolved to accept a tender offer from Taiyo Kosan Co., Inc. for all 420,534 shares of Hisamitsu Pharmaceutical Co., Inc. that it holds as cross-shareholdings, at a price of ¥6,082 per share for total planned proceeds of about ¥2.56 billion. The divestment, which follows Hisamitsu’s own board approval of the offer terms, is expected to generate approximately ¥2.41 billion in extraordinary income as a gain on sales of investment securities in Takasago’s fiscal year ending March 31, 2026, potentially strengthening its balance sheet and giving the company more financial flexibility, while also aligning with ongoing market pressure in Japan to unwind cross-shareholdings.
The most recent analyst rating on (JP:4914) stock is a Buy with a Yen1760.00 price target. To see the full list of analyst forecasts on Takasago International Corporation stock, see the JP:4914 Stock Forecast page.
More about Takasago International Corporation
Takasago International Corporation is a Japanese company listed on the TSE Prime Market (securities code 4914), operating in the flavors, fragrances, and related ingredients industry, supplying specialty aroma and taste solutions to consumer goods and food manufacturers worldwide.
Average Trading Volume: 200,589
Technical Sentiment Signal: Buy
Current Market Cap: Yen151.3B
For a thorough assessment of 4914 stock, go to TipRanks’ Stock Analysis page.